Why timing is everything in AMD: Surgeons' goal should be maintaining functional vision in a higher proportion of patients

ANTI-VASCULAR ENDOTHELIAL growth factor (VEGF) treatment has undoubtedly revolutionized how ophthalmologists manage patients with wet age-related macular degeneration (AMD). Unfortunately, after more than a decade of the current anti-VEGF monotherapy [...]